Neurocrine Biosciences Inc (NBIX)
138.65
-1.60
(-1.14%)
USD |
NASDAQ |
Apr 24, 15:20
Neurocrine Biosciences Price to Book Value: 6.181 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 6.253 |
| April 22, 2024 | 5.959 |
| April 19, 2024 | 5.885 |
| April 18, 2024 | 5.909 |
| April 17, 2024 | 5.940 |
| April 16, 2024 | 5.929 |
| April 15, 2024 | 5.873 |
| April 12, 2024 | 6.003 |
| April 11, 2024 | 6.060 |
| April 10, 2024 | 6.156 |
| April 09, 2024 | 6.194 |
| April 08, 2024 | 6.216 |
| April 05, 2024 | 6.193 |
| April 04, 2024 | 6.135 |
| April 03, 2024 | 6.134 |
| April 02, 2024 | 6.141 |
| April 01, 2024 | 6.303 |
| March 28, 2024 | 6.149 |
| March 27, 2024 | 6.145 |
| March 26, 2024 | 6.293 |
| March 25, 2024 | 6.253 |
| March 22, 2024 | 6.305 |
| March 21, 2024 | 6.408 |
| March 20, 2024 | 6.270 |
| March 19, 2024 | 6.280 |
| Date | Value |
|---|---|
| March 18, 2024 | 6.216 |
| March 15, 2024 | 6.201 |
| March 14, 2024 | 6.204 |
| March 13, 2024 | 6.322 |
| March 12, 2024 | 6.141 |
| March 11, 2024 | 6.180 |
| March 08, 2024 | 6.207 |
| March 07, 2024 | 6.033 |
| March 06, 2024 | 5.896 |
| March 05, 2024 | 5.959 |
| March 04, 2024 | 5.935 |
| March 01, 2024 | 5.854 |
| February 29, 2024 | 5.814 |
| February 28, 2024 | 6.003 |
| February 27, 2024 | 6.064 |
| February 26, 2024 | 6.044 |
| February 23, 2024 | 5.982 |
| February 22, 2024 | 5.946 |
| February 21, 2024 | 5.825 |
| February 20, 2024 | 5.914 |
| February 16, 2024 | 5.899 |
| February 15, 2024 | 5.974 |
| February 14, 2024 | 5.875 |
| February 13, 2024 | 5.967 |
| February 12, 2024 | 5.815 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.952
Minimum
Jul 07 2023
19.22
Maximum
Sep 19 2019
9.375
Average
7.162
Median
Price to Book Value Benchmarks
| Globus Medical Inc | 1.739 |
| Inspire Medical Systems Inc | 12.19 |
| AIM ImmunoTech Inc | 2.311 |
| Protalix BioTherapeutics Inc | 2.655 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 57.29 |
| PS Ratio | 7.358 |
| PEG Ratio | 0.9849 |
| Price to Free Cash Flow | 38.40 |
| Price | 138.65 |
| Earnings Yield | 1.75% |
| Market Cap | 13.80B |
| PEGY Ratio | 0.9849 |
| Operating PE Ratio | 35.17 |
| Normalized PE Ratio | 48.52 |